140 related articles for article (PubMed ID: 18077617)
21. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies.
Zahariadis G; Severini A
Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937
[TBL] [Abstract][Full Text] [Related]
22. Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies.
Qutub MO; Klapper PE; Vallely PJ; Cleator GM; Mandall D
Saudi Med J; 2006 Jun; 27(6):788-93. PubMed ID: 16758036
[TBL] [Abstract][Full Text] [Related]
23. [Serological response to herpes simplex virus type 1 and 2 infection among women of reproductive age].
Dordević H
Med Pregl; 2006; 59(11-12):591-7. PubMed ID: 17633904
[TBL] [Abstract][Full Text] [Related]
24. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.
van Dyck E; Buvé A; Weiss HA; Glynn JR; Brown DW; De Deken B; Parry J; Hayes RJ
J Clin Microbiol; 2004 Jul; 42(7):2961-5. PubMed ID: 15243045
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
Eing BR; Lippelt L; Lorentzen EU; Hafezi W; Schlumberger W; Steinhagen K; Kühn JE
J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
[TBL] [Abstract][Full Text] [Related]
26. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
Morrow RA; Friedrich D; Meier A; Corey L
BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
[TBL] [Abstract][Full Text] [Related]
27. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.
Reddy SM; Balakrishnan P; Uma S; Thyagarajan SP; Solomon S
Clin Diagn Lab Immunol; 2005 Feb; 12(2):359-60. PubMed ID: 15699434
[TBL] [Abstract][Full Text] [Related]
28. Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
Agyemang E; Le QA; Warren T; Magaret AS; Selke S; Johnston C; Jerome KR; Wald A
Sex Transm Dis; 2017 Dec; 44(12):763-767. PubMed ID: 28876290
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.
Hobbs MM; Mwanyumba SW; Luseno WK; Hartman S; Halpern CT; Hallfors DD; Cho H
Sex Transm Dis; 2017 Feb; 44(2):101-103. PubMed ID: 28081046
[TBL] [Abstract][Full Text] [Related]
30. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
[TBL] [Abstract][Full Text] [Related]
31. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition.
Hogrefe W; Su X; Song J; Ashley R; Kong L
J Clin Microbiol; 2002 Oct; 40(10):3635-40. PubMed ID: 12354858
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma.
Groen J; Hersmus B; Niesters HG; Roest W; van Dijk G; van der Meijden W; Osterhaus AD
J Clin Virol; 1999 May; 12(3):193-200. PubMed ID: 10382816
[TBL] [Abstract][Full Text] [Related]
33. Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies.
Ackermann G; Ackermann F; Eggers HJ; Wieland U; Kühn JE
J Med Virol; 1998 Aug; 55(4):281-7. PubMed ID: 9661836
[TBL] [Abstract][Full Text] [Related]
34. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.
Kasubi MJ; Nilsen A; Marsden HS; Bergström T; Langeland N; Haarr L
J Clin Microbiol; 2006 Aug; 44(8):2801-7. PubMed ID: 16891495
[TBL] [Abstract][Full Text] [Related]
36. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2.
Morrow RA; Brown ZA
Am J Obstet Gynecol; 2005 Aug; 193(2):361-2. PubMed ID: 16098855
[TBL] [Abstract][Full Text] [Related]
37. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies.
Scheper T; Saschenbrecker S; Steinhagen K; Sauerbrei A; Suer W; Meyer W; Schlumberger W; Wandinger KP
J Virol Methods; 2010 Jun; 166(1-2):42-7. PubMed ID: 20171247
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa.
Gopal R; Gibbs T; Slomka MJ; Whitworth J; Carpenter LM; Vyse A; Brown DW
J Virol Methods; 2000 Jun; 87(1-2):71-80. PubMed ID: 10856754
[TBL] [Abstract][Full Text] [Related]
39. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Sauerbrei A; Wutzler P
J Virol Methods; 2007 Sep; 144(1-2):138-42. PubMed ID: 17548119
[TBL] [Abstract][Full Text] [Related]
40. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]